The first multi-behavior brain upload
35
votes
Showing only topics with the tag "bio".
Back to normal view
-
-
Living human brain cells play DOOM on a CL1
25 votes -
AutoEnricher: System can diagnose infections in twenty minutes, aiding fight against drug resistance
12 votes -
Where the power is - book review of "White Light: The Elemental Role of Phosphorus – in Our Cells, in Our Food and in Our World"
5 votes -
Coffee fortified with iron—new microparticles can be added to food and beverages to fight malnutrition
20 votes -
Synthetic sugar-coated nanoparticle blocks Covid-19 from infecting human cells
22 votes -
Would you get sick in the name of science?
11 votes -
Edible microlasers made from food-safe materials can serve as barcodes and biosensors
24 votes -
Michael Levin - "Communication With Intelligence in Unconventional Embodiments"
5 votes -
Food and Drug Administration clears Wildtype’s cell-cultivated salmon for US debut
13 votes -
Valve CEO Gabe Newell’s Neuralink competitor, Starfish Neuroscience, is expecting its first brain chip this year
49 votes -
23andMe sells its most valuable asset to biotech company Regeneron, which promises to keep your DNA private
43 votes -
World’s first gene-edited spider produces red fluorescent silk
15 votes -
Startups are making synthetic butter and oil
12 votes -
Gene-edited non-browning banana could cut food waste
24 votes -
23andMe files for bankruptcy
46 votes -
Virologists are still bringing dangerous, novel pathogens in from the wild
11 votes -
Melbourne start-up launches 'biological computer' made of human brain cells
9 votes -
Scientists have bred "Woolly Mice" on their journey to bring back the mammoth
40 votes -
Carved into rock beneath the Swedish city of Västerås, a huge man-made cave system is being used to heat local housing
10 votes -
Fire from the storm: Chemical release at bio-lab
8 votes -
Sweden's green industry hopes hit by Northvolt woes – growing calls for increased state support to help Sweden maintain its position in future technologies
12 votes -
Mitochondria are alive
14 votes -
AI for bio: State of the field
2 votes -
In the quest for electric planes, hybrid may be the answer
8 votes -
Neuralink: PRIME study progress update — second participant
8 votes -
Maglev titanium heart now whirs inside the chest of a live patient
24 votes -
Six distinct types of depression identified in Stanford Medicine-led study
51 votes -
IVF alone can’t save us from a looming fertility crisis
20 votes -
How AI revolutionized protein science, but didn’t end it
16 votes -
Smiling robot face is made from living human skin cells
20 votes -
Patents based on traditional knowledge are often ‘biopiracy’. A new international treaty will finally combat this.
18 votes -
Meet the Finnish biotech startup bringing a long lost mycoprotein to your plate – proprietary single-cell fungus-based protein was originally developed by local paper industry
5 votes -
Enzymes open new path to universal donor blood
12 votes -
US biotech executive sentenced to seven years in jail for COVID test fraud
18 votes -
The influencer who “reverses” Lupus with smoothies. Psychiatrist Brooke Goldner makes extraordinary claims about incurable diseases. It’s brought her a mansion, a Ferrari, and a huge social following.
18 votes -
It’s hearty, it’s meaty, it’s mold
18 votes -
23andMe’s fall from $6 billion to nearly $0
25 votes -
DNA from stone age chewing gum sheds light on diet and disease in Scandinavia's ancient hunter-gatherers
11 votes -
Embracing idiosyncrasies over optimization: The path to innovation in biotechnological design
3 votes -
Tallow to margarine
11 votes -
Brain tissue on a chip achieves voice recognition
30 votes -
What am I thankful for this year? Amazing scientific discoveries.
19 votes -
Blood Music by Greg Bear (1983)
7 votes -
New vaccine technology could protect from future viruses and variants
The vaccine antigen technology, developed by the University of Cambridge and spin-out DIOSynVax in early 2020, provided protection against all known variants of SARS-CoV-2 – the virus that causes...
The vaccine antigen technology, developed by the University of Cambridge and spin-out DIOSynVax in early 2020, provided protection against all known variants of SARS-CoV-2 – the virus that causes COVID-19 – as well as other major coronaviruses, including those that caused the first SARS epidemic in 2002.
The studies in mice, rabbits and guinea pigs [...] found that the vaccine candidate provided a strong immune response against a range of coronaviruses by targeting the parts of the virus that are required for replication.
Professor Jonathan Heeney from Cambridge’s Department of Veterinary Medicine, who led the research, [said] “We wanted to come up with a vaccine that wouldn’t only protect against SARS-CoV-2, but all its relatives.”
18 votes -
Growing living rat neurons to play... DOOM?
20 votes -
Human trials of artificial wombs could start soon. Here’s what you need to know
11 votes -
How to regulate AI? Bioethicist David Magnus on medicine’s critical moment.
4 votes -
Will it slip or will it grip: Scientists ask, “what is snail mucus?”
12 votes -
Thermo Fisher Scientific settles with family of Henrietta Lacks, whose HeLa cells uphold medicine
26 votes